Detalhe da pesquisa
1.
Risk Factors for Seborrhoeic Dermatitis Flares: Case-control and Case-crossover Study.
Acta Derm Venereol
; 100(17): adv00292, 2020 Oct 14.
Artigo
Inglês
| MEDLINE | ID: mdl-33047149
2.
Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study.
Eur Respir J
; 51(3)2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29545318
3.
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT).
Lancet
; 387(10026): 1415-1426, 2016 Apr 02.
Artigo
Inglês
| MEDLINE | ID: mdl-26777916
4.
Association between lung cancer somatic mutations and occupational exposure in never-smokers.
Eur Respir J
; 50(4)2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29074543
5.
EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice.
Eur Respir J
; 50(2)2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28798090
6.
No impact of passive smoke on the somatic profile of lung cancers in never-smokers.
Eur Respir J
; 45(5): 1415-25, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25745045
7.
BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers.
Eur Respir J
; 45(5): 1403-14, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25657019
8.
Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times.
Eur Respir J
; 51(6)2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29929958
9.
Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study.
Clin Lung Cancer
; 24(1): 1-10, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36180314
10.
Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world study.
Lung Cancer
; 185: 107379, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37757576
11.
Routine molecular profiling of patients with NSCLC - Authors' reply.
Lancet
; 388(10049): 1054-1055, 2016 09 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27628516
12.
Prevalence of low bone mineral density in men and women infected with human immunodeficiency virus 1 and a proposal for screening strategy.
J Clin Densitom
; 15(4): 422-433, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22819139
13.
Central Nervous System Metastases in Thymic Epithelial Tumors: A Brief Report of Real-World Insight From RYTHMIC.
J Thorac Oncol
; 16(12): 2144-2149, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34455064
14.
Genotype-phenotype correlations in fetuses and neonates with autosomal recessive polycystic kidney disease.
Kidney Int
; 77(4): 350-8, 2010 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19940839
15.
High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study.
J Thorac Oncol
; 15(1): 120-124, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31605799
16.
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project.
Lung Cancer
; 140: 19-26, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31841714
17.
Clinical outcomes of non-small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France study.
Eur J Cancer
; 116: 86-97, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31181537
18.
Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers France.
J Thorac Oncol
; 12(6): 963-973, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28189832
19.
Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study.
Oncotarget
; 8(13): 21903-21917, 2017 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-28423535
20.
Environmental boron exposure and activity of delta-aminolevulinic acid dehydratase (ALA-D) in a newborn population.
Toxicol Sci
; 80(2): 304-9, 2004 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-15141099